13F filerCIK 1061768 ↗

Baupost Group

You are looking at Q4 2016. See the latest, Q3 2026 →

Reported value

$7.67B

+9.0% on the quarter before

Positions

44

13 new, 13 sold out

Top 10

71.7%

of the value

Est. gain

+$83.0M

on stocks held all quarter

Est. return

+1.4%

on those stocks since Q3 2016

Filed

Feb 14, 2017

On SEC EDGAR ↗

Positions as of Dec 31, 2016, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.

Cheniere Energy Inc12%
Viasat Inc11%
Synchrony Finl9.8%
Allergan Plc9.4%
Twenty First Centy Fox Inc7.0%
20 others6.9%
Pbf Energy Inc5.7%
Dell Technologies Inc4.8%
Antero Res Corp4.5%
Theravance Biopharma Inc3.9%
Northstar Asset Mgmt Group I3.6%
Northstar Rlty Fin Corp2.9%
Twenty First Centy Fox Inc2.6%
Veritiv Corp2.1%
Innoviva Inc2.1%
Keryx Biopharmaceuticals Inc2.0%
Colony Cap Inc1.8%
Mckesson Corp1.8%
Forward Pharma A/S1.0%
Atara Biotherapeutics Inc1.0%
Cardinal Health Inc1.0%
0.8%
0.8%
0.8%
0.7%

Largest buys

Since Q3 2016, sized at quarter-end prices.

  1. Allergan Plc~$300.4MAdded, 6.6% → 9.4% of the portfolio+1,430,625 shares
  2. Twenty First Centy Fox Inc~$179.2MAdded, 4.4% → 7.0% of the portfolio+6,391,000 shares
  3. Mckesson Corp~$140.4MNew, 0.0% → 1.8% of the portfolio+1,000,000 shares
  4. Northstar Rlty Fin Corp~$137.5MAdded, 1.0% → 2.9% of the portfolio+9,078,873 shares
  5. Northstar Asset Mgmt Group I~$131.2MAdded, 1.8% → 3.6% of the portfolio+8,791,346 shares
  6. Synchrony Finl~$112.4MAdded, 7.0% → 9.8% of the portfolio+3,100,000 shares
  7. Viasat Inc~$107.6MAdded, 12.2% → 11.4% of the portfolio+1,625,000 shares
  8. Cardinal Health Inc~$74.1MNew, 0.0% → 1.0% of the portfolio+1,030,000 shares
  9. Theravance Biopharma Inc~$61.3MAdded, 3.8% → 3.9% of the portfolio+1,923,000 shares
  10. Syngenta Ag~$58.9MNew, 0.0% → 0.8% of the portfolio+745,136 shares

Largest sells

Since Q3 2016, sized at quarter-end prices.

  1. Cheniere Energy Inc~$253.4MCut, 17.3% → 11.7% of the portfolio−6,116,617 shares
  2. PayPal~$204.8MSold out, 2.9% → 0.0% of the portfolio−5,000,000 shares
  3. Olin Corp~$126.8MSold out, 1.8% → 0.0% of the portfolio−6,181,302 shares
  4. Vmware Inc~$117.6MSold out, 1.7% → 0.0% of the portfolio−1,603,889 shares
  5. Liberty Interactive Corp~$98.5MSold out, 1.4% → 0.0% of the portfolio−2,469,533 shares
  6. Chipmos Tech Bermuda Ltd~$74.3MSold out, 1.1% → 0.0% of the portfolio−3,751,853 shares
  7. Klx Inc~$70.4MSold out, 1.0% → 0.0% of the portfolio−2,000,000 shares
  8. Silver Run Acquisition Corp~$59.1MSold out, 0.8% → 0.0% of the portfolio−3,750,000 shares
  9. Office Depot Inc~$46.4MSold out, 0.7% → 0.0% of the portfolio−13,000,000 shares
  10. Cascadian Therapeutics Inc~$41.0MSold out, 0.6% → 0.0% of the portfolio−25,000,000 shares

Holdings

As of Dec 31, 2016; changes in shares since Sep 30, 2016.

Positions, sorted by share of the portfolio
HoldingValue
Cheniere Energy IncCOM NEW · shares −22% · price −5.0%11.7%$900.1M−$47.1M
Viasat IncCOM · shares +14% · price −11.3%11.4%$871.3M−$97.2M
Synchrony FinlCOM · shares +18% · price +29.5%9.8%$749.5M+$145.3M
Allergan PlcSHS · shares +71% · price −8.8%9.4%$720.9M−$40.6M
Twenty First Centy Fox IncCL A · shares +50% · price +15.8%7.0%$536.6M+$48.7M
Pbf Energy IncCL A · shares 0% · price +23.1%5.7%$438.4M+$82.4M
Dell Technologies IncCOM CL V · shares 0% · price +15.0%4.8%$365.7M+$47.7M
Antero Res CorpCOM · shares 0% · price −12.2%4.5%$343.1M−$47.9M
Theravance Biopharma IncCOM · shares +26% · price −12.0%3.9%$295.7M−$32.1M
Northstar Asset Mgmt Group ICOM · shares +89% · price +15.4%3.6%$279.1M+$19.7M
Northstar Rlty Fin CorpCOM · shares +165% · price +15.0%2.9%$220.8M+$10.9M
Twenty First Centy Fox IncCL B · shares 0% · price +10.1%2.6%$198.3M+$18.3M
Veritiv CorpCOM · shares 0% · price +7.1%2.1%$163.6M+$10.9M
Innoviva IncCOM · shares 0% · price −2.6%2.1%$159.8M−$4.3M
Keryx Biopharmaceuticals IncCOM · shares 0% · price +10.4%2.0%$151.1M+$14.2M
Colony Cap IncCL A · shares +57% · price +11.1%1.8%$140.9M+$9.0M
Mckesson CorpCOM · shares New1.8%$140.4M—
Forward Pharma A/SSPONSORED ADR · shares 0% · price −28.5%1.0%$80.5M−$32.2M
Atara Biotherapeutics IncCOM · shares 0% · price −33.6%0.99%$76.1M−$38.5M
Cardinal Health IncCOM · shares New0.97%$74.1M—
Liberty Media Corp DelawareCOM C BRAVES GRP · shares 0% · price +18.5%0.80%$61.6M+$9.6M
American Intl Group Inc*W EXP 01/19/202 · shares 0% · price +10.7%0.79%$60.9M+$5.9M
Syngenta AgSPONSORED ADR · shares New0.77%$58.9M—
Liberty Interactive CorpLBT VEN COM A NE · shares New0.71%$54.6M—
Credit Accep Corp MichCOM · shares +144% · price +8.2%0.69%$53.2M+$1.6M
Total 44 positions100%$7.67B+$83.0M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2016 to Q4 2016: 30 stocks held throughout, up $83.0M (+1.4%).

  1. Synchrony Finl+$145.3M+30%
  2. Pbf Energy Inc+$82.4M+23%
  3. Twenty First Centy Fox Inc+$48.7M+16%
  4. Dell Technologies Inc+$47.7M+15%
  5. Northstar Asset Mgmt Group I+$19.7M+15%
  6. Atara Biotherapeutics Inc−$38.5M−34%
  7. Allergan Plc−$40.6M−9%
  8. Cheniere Energy Inc−$47.1M−5%
  9. Antero Res Corp−$47.9M−12%
  10. Viasat Inc−$97.2M−11%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$5.05B−7%SEC ↗
Q2 2026$5.42B+6%SEC ↗
Q1 2026$5.12B−3%SEC ↗
Q4 2025$5.28B+10%SEC ↗
Q3 2025$4.79B+16%SEC ↗
Q2 2025$4.13B+18%SEC ↗
Q1 2025$3.50B+2%SEC ↗
Q4 2024$3.43B−2%SEC ↗
Q3 2024$3.52B−3%SEC ↗
Q2 2024$3.63B−0%SEC ↗
Q1 2024$3.65B−20%SEC ↗
Q4 2023$4.59B−12%SEC ↗
Q3 2023$5.21B−7%SEC ↗
Q2 2023$5.61B−4%SEC ↗
Q1 2023$5.85B−5%SEC ↗
Q4 2022$6.13B+6%SEC ↗
Q3 2022$5.79B−14%SEC ↗
Q2 2022$6.77B−27%SEC ↗
Q1 2022$9.30B−8%SEC ↗
Q4 2021$10.13B−7%SEC ↗
Q3 2021$10.88B−12%SEC ↗
Q2 2021$12.33B−2%SEC ↗
Q1 2021$12.56B+16%SEC ↗
Q4 2020$10.84B+17%SEC ↗
Q3 2020$9.25B+15%SEC ↗
Q2 2020$8.01B+18%SEC ↗
Q1 2020$6.77B−25%SEC ↗
Q4 2019$9.06B+3%SEC ↗
Q3 2019$8.83B−20%SEC ↗
Q2 2019$11.05B−7%SEC ↗
Q1 2019$11.90B+3%SEC ↗
Q4 2018$11.52B−12%SEC ↗
Q3 2018$13.06B+14%SEC ↗
Q2 2018$11.44B+10%SEC ↗
Q1 2018$10.37B+3%SEC ↗
Q4 2017$10.11B+26%SEC ↗
Q3 2017$8.02B−8%SEC ↗
Q2 2017$8.75B+3%SEC ↗
Q1 2017$8.49B+11%SEC ↗
Q4 2016$7.67B+9%SEC ↗
Q3 2016$7.04B−4%SEC ↗
Q2 2016$7.37B+6%SEC ↗
Q1 2016$6.92BSEC ↗

Subscribe to TheInference for free